Search Orphan Drug Designations and Approvals
-
Generic Name: | fomepizole | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Antizole | ||||||||||||||||
Date Designated: | 12/22/1988 | ||||||||||||||||
Orphan Designation: | Treatment of methanol or ethylene glycol poisoning. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Par Pharmaceuticals, Inc 1 Ram Ridge Road Chestnut Ridge, New York 10977 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | fomepizole |
---|---|---|
Trade Name: | Antizole | |
Marketing Approval Date: | 12/04/1997 | |
Approved Labeled Indication: | As an antidote to ethylene glycol (antifreeze) poisoning, or for use in suspected ethylene glycol ingestion. | |
Exclusivity End Date: | 12/04/2004 | |
Exclusivity Protected Indication* : | ||
2 | Generic Name: | fomepizole |
---|---|---|
Trade Name: | Antizole | |
Marketing Approval Date: | 12/08/2000 | |
Approved Labeled Indication: | Use for suspected or confirmed methanol poisoning, either alone or in combination with hemodialysis | |
Exclusivity End Date: | 12/08/2007 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-